[go: up one dir, main page]

GB9804361D0 - Cancer treatment - Google Patents

Cancer treatment

Info

Publication number
GB9804361D0
GB9804361D0 GBGB9804361.5A GB9804361A GB9804361D0 GB 9804361 D0 GB9804361 D0 GB 9804361D0 GB 9804361 A GB9804361 A GB 9804361A GB 9804361 D0 GB9804361 D0 GB 9804361D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9804361.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Priority to GBGB9804361.5A priority Critical patent/GB9804361D0/en
Publication of GB9804361D0 publication Critical patent/GB9804361D0/en
Priority to JP2000534202A priority patent/JP2002505279A/ja
Priority to CA002322856A priority patent/CA2322856A1/fr
Priority to EP99906355A priority patent/EP1058545A1/fr
Priority to AU26320/99A priority patent/AU2632099A/en
Priority to PCT/GB1999/000563 priority patent/WO1999044600A1/fr
Priority to ZA9901619A priority patent/ZA991619B/xx
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9804361.5A 1998-03-02 1998-03-02 Cancer treatment Ceased GB9804361D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9804361.5A GB9804361D0 (en) 1998-03-02 1998-03-02 Cancer treatment
JP2000534202A JP2002505279A (ja) 1998-03-02 1999-02-24 癌管理
CA002322856A CA2322856A1 (fr) 1998-03-02 1999-02-24 Traitement du cancer a l'aide de tamoxifene et d'acide gammalinolenique
EP99906355A EP1058545A1 (fr) 1998-03-02 1999-02-24 Traitement du cancer a l'aide de tamoxifene et d'acide gammalinolenique
AU26320/99A AU2632099A (en) 1998-03-02 1999-02-24 Cancer management with tamoxifen and gammalinolenic acid
PCT/GB1999/000563 WO1999044600A1 (fr) 1998-03-02 1999-02-24 Traitement du cancer a l'aide de tamoxifene et d'acide gammalinolenique
ZA9901619A ZA991619B (en) 1998-03-02 1999-03-01 Cancer management.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804361.5A GB9804361D0 (en) 1998-03-02 1998-03-02 Cancer treatment

Publications (1)

Publication Number Publication Date
GB9804361D0 true GB9804361D0 (en) 1998-04-22

Family

ID=10827820

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9804361.5A Ceased GB9804361D0 (en) 1998-03-02 1998-03-02 Cancer treatment

Country Status (7)

Country Link
EP (1) EP1058545A1 (fr)
JP (1) JP2002505279A (fr)
AU (1) AU2632099A (fr)
CA (1) CA2322856A1 (fr)
GB (1) GB9804361D0 (fr)
WO (1) WO1999044600A1 (fr)
ZA (1) ZA991619B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
JP4382735B2 (ja) 2005-10-06 2009-12-16 独立行政法人科学技術振興機構 神経因性疼痛治療剤
WO2012141575A1 (fr) * 2011-04-14 2012-10-18 N.V.Nutricia Combinaison d'epa, de dpa et/ou de dha avec un agent chimiothérapeutique
US10639313B2 (en) 2017-09-01 2020-05-05 Ndsu Research Foundation Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5574094A (en) * 1992-11-30 1994-06-22 Biosignal Kutato-Fejleszto Kft. Polyunsaturated fatty acyl-peptide composition
NZ280017A (en) * 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
CA2255615C (fr) * 1996-05-22 2006-08-29 Neuromedica, Inc. Compositions comprenant des conjugues d'acide cis-docosahexanoique et de docetaxel

Also Published As

Publication number Publication date
EP1058545A1 (fr) 2000-12-13
AU2632099A (en) 1999-09-20
ZA991619B (en) 2000-01-20
JP2002505279A (ja) 2002-02-19
WO1999044600A1 (fr) 1999-09-10
CA2322856A1 (fr) 1999-09-10

Similar Documents

Publication Publication Date Title
HUP0104857A3 (en) New cancer treatments
GB9800942D0 (en) Well treatment
GB9805877D0 (en) Cancer
GB9816556D0 (en) Therapy
GB0026015D0 (en) Cancer treatment
ZA200203166B (en) Treatment of cancer.
GB9803447D0 (en) Cancer diagnosis
GB9804361D0 (en) Cancer treatment
GB9819999D0 (en) Treatment of cancer
GB9827102D0 (en) New cancer treatments
GB9903035D0 (en) Treating cancer
GB0020261D0 (en) Therapeutic treatment
GB2334579B (en) Treating cancer
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9818023D0 (en) Cancer treatment
GB9820000D0 (en) Cancer treatment
AU4598100A (en) Treating cancer
GB9828550D0 (en) Treatment
GB9812151D0 (en) Treating cancer
GB9914971D0 (en) Treating cancer
GB0007254D0 (en) Treating cancer
GB9927106D0 (en) Cancer treatment
GB9908176D0 (en) Cancer treatment
GB9806039D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)